TriSalus Life Sciences (TLSIW) Interest Expenses (2022 - 2026)

TriSalus Life Sciences (TLSIW) has 5 years of Interest Expenses data on file, last reported at $1.4 million in Q1 2026.

• For the quarter ending Q1 2026, Interest Expenses rose 18.78% year-over-year to $1.4 million; the trailing twelve-month figure through Mar 2026 stood at $5.8 million (up 34.33% YoY), and the FY2025 full-year result was $5.5 million, up 79.42% from the prior year.
• Interest Expenses for Q1 2026 stood at $1.4 million, down from $1.5 million in the prior quarter.
• Across five years, Interest Expenses topped out at $1.5 million in Q3 2025 and bottomed at $1000.0 in Q4 2022.
• The 5-year median for Interest Expenses is $972500.0 (2024), against an average of $720500.0.
• The widest annual swing landed in 2024, when Interest Expenses slumped 40.0%; it then surged 40200.0% in 2025.
• A 5-year view of Interest Expenses shows it stood at $1000.0 in 2022, then soared by 200.0% to $3000.0 in 2023, then soared by 35500.0% to $1.1 million in 2024, then jumped by 35.96% to $1.5 million in 2025, then fell by 1.1% to $1.4 million in 2026.
• The last three Interest Expenses figures came in at $1.4 million (Q1 2026), $1.5 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.

Peer Comparison